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Abstract
Background: It is important to find reliable and accessible methods for the diagnosis and identification of fungal species causing hospital
acquired infections. Our main objective was using a rapid and accessible molecular method for the monitoring of Aspergillus infections and
identification of causing agents in the level of species.
Material and Methods: The study subjects were primarily clinical specimens collected from suspected HAI patients with clinical symptoms
after hospitalization. Also some environmental specimens were collected from air and instruments of health care facilities for the investigation of
Aspergillus sources in a university hospital of UMSU, Urmia. All specimens were transported to Medical Mycology Center for the detection and
identification of Aspergillus species using morphological methods. Also molecular method, PCR-RFLP using single restriction enzyme as a rapid
and available method was performed to investigate environmental sources of Aspergillus infections.
Results: Total of 110 clinical fungal isolates included Candida and Aspergillus species and some other opportunistic fungi. Among the clinical
Aspergillus findings, Aspergillus flavus (47%), Aspergillus fumigatus (29.4%) and Aspergillus niger (23.6%) were the most frequent species
respectively and also Aspergillus niger (43.7%), Aspergillus flavus (41.8%), Aspergillus fumigatus (14.7%) were isolated as the most frequent
species from environmental sources.
Conclusion: Because of accessibility, speed and high sensitivity of diagnosis, the PCR-RFLP was very useful for the identification of medically
important Aspergillus species and epidemiological approaches.
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Introduction
Aspergillus species as opportunistic fungi are found in soil, water and decaying vegetation. They are also isolated from unfiltered air,
ventilation systems, false ceiling dust, contaminated dust dislodged during hospital renovation and construction. Catheters and implants might be
colonized by Aspergillus species (Warris and Verweij, 2005). There is plenty of evidence supporting the role of these fungi as agents of hospital
acquired infections (HAIs) (Dancer et al., 2009). The primary route of acquiring Aspergillus infection is by inhalation of the fungal spores. In
severely immunosuppressed patients, pneumonia results from local lung tissue invasion. In addition, the fungus may disseminate through the
bloodstream to deep organs. Patients with severe, prolonged, granulocytopenia, especially bone-marrow transplant recipients, are at the highest
risk. A. fumigatus and A. flavus are the most frequently isolated species in patients with proven aspergillosis (Verweij et al., 2002). The presence
of invasive disease may be inferred by the clinical symptoms and signs, and images obtained by CT scanning etc.
It is important to find reliable and accurate methods for the identification of fungal agents of HAIs and epidemiological approaches as
well. Aspergillus infections are difficult to diagnose at early stages and conventional microbiological, serologic or imaging techniques are often
insufficient to ensure the early diagnosis and identifications. Tissue invasion, as demonstrated by examination of biopsy material, provides
unequivocal evidence of invasive disease, and blood cultures are usually negative (Healy et al., 2004).
Recently, some immunological and molecular tests were used for the identification of Aspergillus species causing HAIs (Verweij et al.,
2002; Healy et al., 2004). Different molecular methods such as restriction fragment length polymorphism (RFLP) based on amplification of
ribosomal RNA have been employed to identify Aspergilli in the level of species (Moody and Tyler, 1990). Because of facility in use, speed,
availability and high sensitivity of diagnosis, PCR-RFLP using single restriction enzyme was studied in this study for the identification of
Aspergillus species isolated from the HAI patients and the hospital indoor environments (Mirhendi and Diba, 2007).
Materials and Methods
Clinical and environmental specimens
Our main subjects were clinical specimens including; sputum, bronchoalveolar lavage (BAL), sinus discharge, urine and synovial fluid
collected from HAI suspected patients with clinical symptoms after hospitalization. The presence of invasive disease was inferred by the clinical
symptoms and signs, and images obtained by CT scanning etc. and fungal colonization was suggested by frequently isolation of organisms from
cultures while there are no clinical symptoms. All specimens were transported to Medical Mycology Center, UMSU, Urmia. The morphological
diagnosis was performed using growth characteristics on Sabouraud glucose agar 4% and microscopic features for the identification of
Aspergillus species (Raper and Fennell, 1965). Also some environmental specimens were collected from air and instruments of health care
facilities including: surfaces of the walls, carpets, beds and blankets, trolleys, air condition, medical devices and also finger touch samples of
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cases, health care workers (HCWs) and visitors. Air samples were collected by using Sabouraud glucose agar (SGA4%) plates which left
uncapped expose to blowing air and the other samples were taken with sterile swabs and inoculated on a transport medium like SGA4% (Diba et
al., 2007). Also the molecular method, PCR-RFLP using single restriction enzyme as a rapid and available method was performed to investigate
environmental sources of Aspergillus infections.
DNA extraction
It was necessary to prepare Aspergillus mycelia mass which is filtered and purified from the 12-24 hours fungal liquid cultures.
Genomic DNA was extracted from Aspergillus mycelia mass by glass beads in a lysis buffer (1mM EDTA, 1% SDS, 100mM NaCl, 10mM Tris-
HCl, 2% Triton X-100, PH: 8.0) followed by conventional phenol-chloroform method. The extracted DNA was checked by using agarose gel
electrophoresis (Loeffler et al., 2002).
PCR amplification
The PCR assay was performed using 5 µl of the DNA template in a total reaction volume of 50 µl (consisting of PCR buffer (20 mM
Tris- HCL at pH 8.0), 50 mM KCL, 0.1 mM each of forward (ITS: 5-TCC GTA GGT GAA CCT GCG G-3) and reverse (ITS-4 5-TCC TCC
GCT TAT TGA TAT GC-3) primers for ITS regions of rDNA (purchased from Mirhendi Molecular Biology Center, TUMS), and 1.5 U of Taq
DNA polymerase. We used universal primers for the amplification of Aspergillus ITS regions (Forward Primer: 5'- TCC GTA GGT GAA CCT
GCG G - 3' Reverse Primer: 5'- TCC TCC GCT TAT TGAT TAT GC - 3'). All reactions were performed in a Thermocycler model XL (Bioer,
China). Thermal program included an initial DNA denaturation at 95 °C for 5 min that followed by 30 cycles. Each cycle consisted of a
denaturation step at 95 °C for 30 s, an annealing step at 55°C for 30 s, and an extension step at 72°C for 1 min, with a final extension at 72 °C for
5 min following the last cycle. For all PCRs, we had a negative control and a positive control as well. Double deionized water (DDW, Merck,
Germany) was used as negative control and DNA template extracted (Boiling, Phenol-Chloroform method) from standard Candida strain: C.
albicans (ATCC 10261), was employed as positive control. The DNA fragments were length separated by electrophoresis through 1.5% agarose
gels in Tris Borate EDTA buffer and 0.50 mg ethidium bromide per ml. Results were documented by using a tarns illuminator, Gel Doc System
(Figure 1).
Digestion of PCR products using RFLP method
The method of restriction fragment length polymorphism was used to make differential pattern for the identification of Aspergillus spp.
(Martínez-Culebras and Ramón, 2007). Digestion of amplified ITS fragments with our restriction enzyme, MwoI at 37 °C enabled us to
differentiate some medically relevant Aspergillus species. It was performed on all clinical and environmental Aspergillus isolates. For the
restriction digestion, 13 µl of each PCR product was directly digested by 5 U (0.5 µl) of the restriction enzyme, 1.5 µl of the enzyme buffer, and
incubated at 37 °C for 180 min (Almirante et al., 2005). Digested PCR products were subjected to electrophoresis in a 2% agarose gel and
visualized with gel doc system. Molecular identification of Aspergillus species was performed comparing the electrophoresis bands with
differential patterns (Figure 2).
Figure 1: Agarose gel electrophoresis of amplified ITS fragments of Aspergillus species. , Lane I: A.niger, Lanes 2-5: A. flavus , Lanes: 6,7: A.
fumigatus and Lane 8: A frequently tested A. fumigatus as positive control and M: 100 bp DNA ladder. As it shown, approximately all
species make the same size PCR bands on agarose gel.
Results
The results of experimental studies on 198 clinical specimens showed totally 93 (47%) fungal or bacterial infections. Among all
positive cases, 54 (58%) had a fungal infection, supposing that all of the isolated fungi were causing agents of nosocomial infections with clinical
symptoms after hospitalization. The isolated fungi included, 36 Candida spp. (66.6%) and 17 Aspergillus spp. (31.4%). Among the clinical
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isolated Aspergillus species; A. flavus (47%), A. fumigatus (29.4%) and A. niger (23.6%) were the most frequent species respectively (Table 1).
The black filamentous mold ‘Alternaria alternata’ was the only non Candida, non Aspergillus isolated fungus in this study which was isolated
from synovial sample of a patient with septic arthritis. All identifications findings were confirmed by PCR-RFLP method (Figure 2). Among all
environmental specimens, 256 specimens were collected from finger touch and body surface samples of patients, personnel and visitors, bed,
floor, walls, trolleys, sink, medical devices and air samples (Table 2) which made up 110 fungal isolates including Candida, Aspergillus spp. and
other fungi as saprophytic molds: Alternaria, Saccharomyces, Mucorals, Penicillium, Cladosporidium and Pheohyphomycetes. Among all
isolates, Candida spp. 35(31.5%), Aspergillus spp. 48(43.2%) and other fungi 28(20.3%) were included. Environmental Aspergillus isolates were:
A. niger (43.7%), A. flavus (41.8%) and A. fumigatus (14.7%) (Table 1).
Figure 2: Agarose gel electrophoresis of ITS PCR products from standard Aspergillus species after digestion with the restriction enzyme MwoI.
Lanes ST: standard Aspergillus species as positive control, lanes 1, 3, 5, 6: A. flavus, lanes 2, 4, 7: A. fumigatus, Lane M: 100 bp DNA
ladder.
Table 1: Identification of Aspergillus species isolated from clinical and environmental sources by RFLP method as
well as their frequencies.
TotalEnvironmental specimensClinical specimens
%No.%No.%No.
43.12841.720478A. flavus
38.52543.72123.54A. niger
18.41214.6729.55A. fumigatus
100651004810017Total
Table 2: The frequency of opportunistic fungi isolated from air, instruments, indoor /outdoor surfaces (number of isolations) and finger touch of
patients, HCWs and visitors. The last specimens are very important in the transmission of Candida spp.
* Health care worker
Discussion
There is plenty of evidence supporting the role of opportunistic fungi as important agents of HAIs. During the period 1980-90
Aspergillus species emerged as causing agents of life-threatening infections in immuno-compromised patients (Martínez-Culebras and Ramón,
2007). Recently, some molecular techniques were used for the detection and identification of opportunistic fungi including Aspergillus spp. Susan
F. Moody and co-worker (Moody and Tyler, 1995) used the PCR-RFLP for the analysis of inter species variations of Aspergillus group flavi: A.
flavus, A. parasiticus, A. nomius. Also Dendis his group (Dendis et al., 2003) performed this method for identifying some pathogenic fungi
isolated from febrile neutropenic patients. Molecular method PCR-RFLP with single restriction enzyme was used by Mirhendi et al. (Mirhendi et
Environmental
specimens
Case HCW Visitor Carpet Walls Bed &
Blanket
Sink Trolleys Medical
devices
Air Air
conditioner
Out
door
Contaminants
Candida 1 5 1 2 4 4 3 1 0 0 0 2
Aspergillus 3 1 0 9 7 7 2 5 1 5 3 8
Other 0 0 0 3 5 4 1 4 6 4 1 0
Total 13 6 1 14 16 15 6 10 7 9 4 10
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al., 2006), for the identification and differentiation of pathogenic fungi such as Candida spp. The PCR-RFLP method using a single restriction
enzyme, MwoI has also been used for the identification of Aspergillus spp. A whole process of molecular identification including, isolation of
fungal agent from a short incubated culture, a profile of DNA extraction, PCR and RFLP, for 6-10 samples takes a long day (12-18 hours)
approximately. It should absolutely be more rapid than classic or morphologic methods of identifications. In the present study the rapid and
reliable method of PCR-RFLP employing MwoΙ enabled us to identify Aspergillus spp. isolated from clinical specimens. Our results of 
Aspergillus isolation showed that A. fumigatus and A. flavus were the most frequent Aspergillus species isolated from cases with proven
aspergillosis. Likewise our findings of environmental isolates showed that more than 50% of all samples were positive for at least an
opportunistic fungus. From all of the tested samples, carpets, walls and beds were the most contaminated surfaces by the above fungi.
Considering the frequent and long time contacts between the above surfaces and cases, personnel and visitors, It could be a reasonable
explanation for that result. It is important the most hospital yeast isolates were obtained from cases and personnel finger touch samples (Table 2).
Aspergillus species (the second group of medically important fungi causing HAIs) are obtained from air and indoor/outdoor hospital environment.
The most contaminated hospital indoor places in our study were the carpets, walls and also air samples of rooms (Dancer et al., 2009). The
primary route of acquiring Aspergillus spp. is inhalation of the spores within aerosols suspended in air. Hospital renovations or constructions are
capable of liberating large numbers of fungal spores into the health care units (Warris and Verweij, 2005). Although isolation of Aspergillus
spores from air samples was not considered in this study.
Comparing various differential methods for the identification of Aspergillus species including conventional and molecular tests,
because of it's accessibility, speed and high sensitivity of diagnosis, the PCR-RFLP was very useful for the identification of medically important
Aspergillus species and epidemiological approaches.
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